Compare

Fitlife Brands, Inc. vs Mannatech Inc vs Niagen Bioscience, Inc. vs Natural Alternatives International Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearFitlife Brands, Inc.
FTLF
Mannatech Inc
MTEX
Niagen Bioscience, Inc.
NAGE
Natural Alternatives International Inc
NAII
Year ended2025-12-312025-12-312025-12-312026-06-30
Revenue$81.46M$108.04M$129.42M$142.51M
Revenue growth (YoY)+26.4%-8.3%+29.9%+9.7%
Gross margin38.6%74.9%64.3%6.3%
Operating margin12.4%-0.4%12.6%-13.2%
Net margin7.8%-14.1%13.4%-14.5%
Net income$6.33M-$15.21M$17.38M-$20.70M
EPS (Diluted)$0.63-$8.00$0.20-$3.43
Operating cash flow$7.44M-$2.96M$13.50M-$8.92M
Free cash flow$7.40M-$4.32Mn/a-$12.62M
Cash & equivalentsn/a$6.18Mn/a$7.39M
Total assets$106.32M$29.99M$106.41M$126.45M
Total liabilities$62.68M$35.22M$29.87M$76.49M
Shareholders' equity$43.64M-$5.22M$76.53M$49.96M
Return on year-end equity14.5%n/a22.7%-41.4%
Shares outstanding9.39M1.90M79.71M6.27M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearFitlife Brands, Inc.Mannatech IncNiagen Bioscience, Inc.Natural Alternatives International Inc
Latest$81.46M
Ended 2025-12-31
$108.04M
Ended 2025-12-31
$129.42M
Ended 2025-12-31
$142.51M
Ended 2026-06-30
1 year earlier$64.47M
Ended 2024-12-31
$117.87M
Ended 2024-12-31
$99.60M
Ended 2024-12-31
$129.86M
Ended 2025-06-30
2 years earlier$52.70M
Ended 2023-12-31
$131.96M
Ended 2023-12-31
$83.57M
Ended 2023-12-31
$113.80M
Ended 2024-06-30
3 years earlier$28.80M
Ended 2022-12-31
$137.21M
Ended 2022-12-31
$72.05M
Ended 2022-12-31
$154.01M
Ended 2023-06-30
4 years earlier$27.91M
Ended 2021-12-31
$159.76M
Ended 2021-12-31
$67.45M
Ended 2021-12-31
$170.97M
Ended 2022-06-30